HONG KONG -- At 28, Dai Wenyuan quit his job developing artificial intelligence software for Chinese internet giant Baidu to launch his own company. It was a smart move: his AI start-up quickly attracted an initial $4 million investment from Sequoia Capital China in 2015.
Three years later, Dai's company is capturing attention for developing a medical tool that uses AI to predict whether patients are at risk of developing diabetes. His company, 4Paradigm, said its accuracy rate was 88%.
